{"product_id":"9781118468579","title":"Targeted Therapy in Translational Cancer Research","description":"\u003ch3\u003eTranslational Oncology\u003c\/h3\u003e\u003ch1\u003eTargeted Therapy in Translational Cancer Research\u003c\/h1\u003e\u003ch3\u003eApostolia-Maria Tsimberidou | Razelle Kurzrock | Kenneth C. Anderson | Robert C. Bast | Maurie Markman | Ernest Hawk\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eMedical \/ Oncology \/ General\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003e\n\u003ci\u003eTargeted Therapy in Translational Cancer Research\u003c\/i\u003e for the \u003ci\u003eTranslational Oncology\u003c\/i\u003e series provides a comprehensive overview of recent developments in our understanding of tumor biology, elucidates the roles of targets and pathways involved in carcinogenesis, and describes current state-of-the-art anticancer therapy, as well as the most promising areas of translational research and targeted therapy.\u003cbr\u003e\u003cbr\u003e \u003cul\u003e \u003cli\u003eIntroduces cutting-edge ‘bench to bedside and back’ breakthroughs which have transformed the diagnosis, prognosis, and treatment of cancer\u003c\/li\u003e \u003cli\u003eCovers basic principles of targeted therapy, including immunotherapy and the roles of cancer stem cells, the microenvironment, angiogenesis, epigenetics, microRNAs, and functional imaging in precision medicine\u003c\/li\u003e \u003cli\u003eSummarises major advances in therapeutic management of hematologic malignancies and solid tumors using conventional therapy, targeted therapy, immunotherapy, or novel treatment modalities\u003c\/li\u003e \u003c\/ul\u003e\n\u003c\/div\u003e\u003cdiv\u003e Apostolia-Maria Tsimberidou, MD PhD\u003cbr\u003eDepartment of Investigational Cancer Therapeutics\u003cbr\u003eThe University of Texas MD Anderson Cancer Center\u003cbr\u003eHouston, TX, USA\u003cbr\u003e\u003cbr\u003eRazelle Kurzrock\u003cbr\u003eCenter for Personalized Cancer Therapy, UC San Diego - Moores Cancer Center\u003cbr\u003eLa Jolla, CA, USA\u003cbr\u003e\u003cbr\u003eKenneth C. Anderson MD\u003cbr\u003eLeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School\u003cbr\u003eBoston, MA, USA\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e21 December 2015\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley-Blackwell\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9781118468579\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e400\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e47.2\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44380493545612,"sku":"9781118468579","price":155.66,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9781118468579_21a64836-8e41-4ffc-98fd-ff30d057eefc.jpg?v=1780237505","url":"https:\/\/fh90cf-fv.myshopify.com\/products\/9781118468579","provider":"Late Knight Books and Services, LLC","version":"1.0","type":"link"}